These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32418657)

  • 1. Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease.
    Chávez-Gutiérrez L; Szaruga M
    Semin Cell Dev Biol; 2020 Sep; 105():75-85. PubMed ID: 32418657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer's Disease.
    Kabir MT; Uddin MS; Setu JR; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Neurotox Res; 2020 Dec; 38(4):833-849. PubMed ID: 32556937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease.
    Weggen S; Beher D
    Alzheimers Res Ther; 2012 Mar; 4(2):9. PubMed ID: 22494386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the Presenilins in the cell biology, structure and function of γ-secretase.
    Escamilla-Ayala A; Wouters R; Sannerud R; Annaert W
    Semin Cell Dev Biol; 2020 Sep; 105():12-26. PubMed ID: 32146031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
    Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
    J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilins: how much more than γ-secretase?!
    Coen K; Annaert W
    Biochem Soc Trans; 2010 Dec; 38(6):1474-8. PubMed ID: 21118110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and Notch signaling.
    Woo HN; Park JS; Gwon AR; Arumugam TV; Jo DG
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1093-7. PubMed ID: 19853579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.
    Czech C; Tremp G; Pradier L
    Prog Neurobiol; 2000 Mar; 60(4):363-84. PubMed ID: 10670705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate recruitment by γ-secretase.
    Fukumori A; Feilen LP; Steiner H
    Semin Cell Dev Biol; 2020 Sep; 105():54-63. PubMed ID: 32331992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis of neurodegeneration in familial Alzheimer's disease.
    Kowalska A
    Pol J Pharmacol; 2004; 56(2):171-8. PubMed ID: 15156067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
    Zhang C; Browne A; Kim DY; Tanzi RE
    Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial L723P Mutation Can Shift the Distribution between the Alternative APP Transmembrane Domain Cleavage Cascades by Local Unfolding of the Ε-Cleavage Site Suggesting a Straightforward Mechanism of Alzheimer's Disease Pathogenesis.
    Bocharov EV; Nadezhdin KD; Urban AS; Volynsky PE; Pavlov KV; Efremov RG; Arseniev AS; Bocharova OV
    ACS Chem Biol; 2019 Jul; 14(7):1573-1582. PubMed ID: 31180641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.